Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
AIDS (London, England)|August 19, 2004
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionAndrew N Phillips, Bruno Ledergerber, Andrezej Horban, et al.
Plos One|August 23, 2012
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA studyJoanne Reekie, Justyna D Kowalska, Igor Karpov, et al.
AIDS (London, England)|November 25, 2011
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapyJustyna D Kowalska, Joanne Reekie, Amanda Mocroft, et al.
The Lancet. HIV|January 15, 2016
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Annals of Internal Medicine|August 21, 2002
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapyOle Kirk, Peter Reiss, Caterina Uberti-Foppa, et al.
AIDS (London, England)|November 15, 2005
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?Amanda Mocroft, Vincent Soriano, Jurgen Rockstroh, et al.
Scandinavian Journal of Infectious Diseases|July 9, 2008
Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cARTDaria Podlekareva, Amanda Mocroft, Ole Kirk, et al.
The Journal of Infectious Diseases|July 23, 2002
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell countsVeronica Miller, Andrew N Phillips, Bonaventura Clotet, et al.
Annals of Neurology|March 3, 2004
Changing incidence of central nervous system diseases in the EuroSIDA cohortAntonella d'Arminio Monforte, Paola Cinque, Amanda Mocroft, et al.
Scandinavian Journal of Infectious Diseases|December 7, 2006
Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis CAmanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
AIDS (London, England)|August 19, 2004
Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionAndrew N Phillips, Bruno Ledergerber, Andrezej Horban, et al.
Plos One|August 23, 2012
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA studyJoanne Reekie, Justyna D Kowalska, Igor Karpov, et al.
AIDS (London, England)|November 25, 2011
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapyJustyna D Kowalska, Joanne Reekie, Amanda Mocroft, et al.
The Lancet. HIV|January 15, 2016
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Annals of Internal Medicine|August 21, 2002
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapyOle Kirk, Peter Reiss, Caterina Uberti-Foppa, et al.
AIDS (London, England)|November 15, 2005
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?Amanda Mocroft, Vincent Soriano, Jurgen Rockstroh, et al.
Scandinavian Journal of Infectious Diseases|July 9, 2008
Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cARTDaria Podlekareva, Amanda Mocroft, Ole Kirk, et al.
The Journal of Infectious Diseases|July 23, 2002
Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell countsVeronica Miller, Andrew N Phillips, Bonaventura Clotet, et al.
Annals of Neurology|March 3, 2004
Changing incidence of central nervous system diseases in the EuroSIDA cohortAntonella d'Arminio Monforte, Paola Cinque, Amanda Mocroft, et al.
Scandinavian Journal of Infectious Diseases|December 7, 2006
Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis CAmanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.
Pageof 18